Search

Your search keyword '"Ferré, Valentine Marie"' showing total 167 results

Search Constraints

Start Over You searched for: Author "Ferré, Valentine Marie" Remove constraint Author: "Ferré, Valentine Marie"
167 results on '"Ferré, Valentine Marie"'

Search Results

7. Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study

9. Viral whole genome sequencing reveals high variations in APOBEC3 editing between HPV risk categories.

10. Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses

16. Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection.

17. Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study

19. Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)–Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58

20. Genomic diversity of mpox virus in Paris area (France) during the 2022 outbreak

22. Phylodynamics of SARS-CoV-2 in France, Europe and the world in 2020

23. Outcomes of Omicron sub-lineages BA.1.1 and BA.2 infection compared with the sub-lineage BA.1 infection in emergency departments' patients

24. Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa

25. Author response: Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020

28. Erythematous maculopapular rash in monkeypox virus infection: A retrospective case series of 30 patients

29. Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project

30. Histological Features Associated With Human Mpox Virus Infection in 2022 Outbreak in a Nonendemic Country

31. Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy

35. Phylodynamics of SARS-CoV-2 transmissions in France, Europe and the world during 2020

36. Breakthrough infections after post-exposure vaccination against Monkeypox

39. Histological Features Associated With Human Mpox Virus Infection in 2022 Outbreak in a Nonendemic Country.

40. Severely impaired humoral response against SARS-CoV-2 variants of concern following two doses of BNT162b2 vaccine in patients with systemic lupus erythematosus (SLE)

41. Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage

43. Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine

44. Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants

46. In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions

47. Erratum to: Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients

48. Healthcare-Associated Infection With Monkeypox Virus of a Healthcare Worker During the 2022 Outbreak.

49. Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2

50. Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses

Catalog

Books, media, physical & digital resources